Cerus Corporation (CERS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

6.25+0.01 (+0.16%)

At close: 4:00PM EDT

6.26 +0.01 (+0.16%)
After hours: 05:03PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	6.24
Open	6.23
Bid	6.23 x 1300
Ask	6.23 x 3100
Day's Range	6.17 - 6.33
52 Week Range	4.67 - 8.87
Volume	605,757
Avg. Volume	1,149,409

Market Cap	1.073B
Beta (5Y Monthly)	1.21
PE Ratio (TTM)	N/A
EPS (TTM)	-0.37
Earnings Date	Nov 02, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	9.40

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CERS

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Cerus Corporation
Analyst Report: Abbott LaboratoriesAbbott Laboratories is a diversified healthcare company that develops, manufactures and markets a wide range of medical products and services. Its main product lines are nutritionals for adults and infants, diagnostic systems, vascular implants, cardiac rhythm management products, and diabetes care products.
Rating
Fair Value
Economic Moat
3 days agoArgus Research

All

News

Press Releases

Research Reports

Business Wire
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
CONCORD, Calif., October 19, 2021--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2021 financial results will be released on Tuesday, November 2, 2021, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.
Insider Monkey
Cathie Wood’s Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks. If you want to skip our detailed analysis of Wood’s history, investment philosophy, and hedge fund performance, go directly to Cathie Wood’s Top 5 Small-Cap Stock Picks. Catherine Wood is an American millionaire investor, who founded ARK Investment Management in 2014. She serves […]
Simply Wall St.
Investors in Cerus (NASDAQ:CERS) have made a return of 10% over the past five years
The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...